CHF and arrhythmias:

Indications for: VYNDAQEL

Treatment in adults with cardiomyopathy of wild type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) to reduce cardiovascular mortality and cardiovascular-related hospitalization.

Adult Dosage:

Swallow whole. 80mg once daily. Not substitutable with Vyndamax on a per mg basis.

Children Dosage:

Not established.

VYNDAQEL Warnings/Precautions:

Pregnancy. Advise females of reproductive potential to consider pregnancy planning and prevention. Nursing mothers: not recommended.

VYNDAQEL Classification:

Transthyretin (TTR) stabilizer.

VYNDAQEL Interactions:

May potentiate BCRP substrates (eg, methotrexate, rosuvastatin, imatinib).

Generic Drug Availability:


How Supplied: